Navamedic ASA (NAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
- GDPH82351D
- Pages: 32
- November 2018
- Total Views:1158
- Region : Europe
- GlobalData
- Equity Research Report

Details
Summary
Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.
Navamedic ASA (NAVA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table Of Content
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navamedic ASA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Navamedic Enters into Agreement with bene-Arzneimittel 12
Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13
Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14
Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16
Navamedic Enters Into Distribution Agreement With Torrent Pharma 17
Navamedic Amends Distribution Agreement With Aspen Pharma 18
Equity Offering 19
Navamedic Raises USD1.3 Million in Private Placement of Shares 19
Navamedic ASA-Key Competitors 20
Navamedic ASA-Key Employees 21
Navamedic ASA-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 24, 2018: Navamedic: Q2 2018 results 23
May 30, 2018: Navamedic Announces Q1 2018 results 24
Feb 15, 2018: Navamedic: Q4 2017 Results 25
Nov 10, 2017: Navamedic: Q3 2017 results 26
Jul 28, 2017: Navamedic ASA: Second quarter results 2017 27
Jul 28, 2017: Navamedic: Second quarter results 2017 28
May 10, 2017: Navamedic: Q1 2017 Results 29
Feb 15, 2017: Navamedic: Q4 2016 results 30
Corporate Communications 31
Oct 01, 2018: Navamedic announce Tom Ronnlund to step down as CEO 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List Of Figure
List of Figures
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Navamedic ASA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Navamedic Enters into Agreement with bene-Arzneimittel 12
Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13
Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14
Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16
Navamedic Enters Into Distribution Agreement With Torrent Pharma 17
Navamedic Amends Distribution Agreement With Aspen Pharma 18
Navamedic Raises USD1.3 Million in Private Placement of Shares 19
Navamedic ASA, Key Competitors 20
Navamedic ASA, Key Employees 21
Navamedic ASA, Subsidiaries 22
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Navamedic ASA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Company Profile
Company Profile Title
Summary
Navamedic ASA (Navamedic) is a medtech and pharmaceutical products company, which develops, distributes and markets medicines and medical equipment. Its product portfolio includes branded, generic and patented pharmaceuticals, medical devices, food supplements and other healthcare products. The company offers its products to patients, hospitals and pharmacies in the Nordic, Benelux and Baltic markets. Navamedic offers its pharmaceutical products under mouth and throat health, dermatology, urology, gynecology, cardiology and other categories; and medical devices under urine measurement and psychiatry categories. The company also distributes products supplied by several pharmaceutical manufacturers. Navamedic is headquartered in Lysaker, Norway.
Navamedic ASA (NAVA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Scope
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navamedic ASA, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Navamedic Enters into Agreement with bene-Arzneimittel 12
Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13
Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14
Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16
Navamedic Enters Into Distribution Agreement With Torrent Pharma 17
Navamedic Amends Distribution Agreement With Aspen Pharma 18
Equity Offering 19
Navamedic Raises USD1.3 Million in Private Placement of Shares 19
Navamedic ASA-Key Competitors 20
Navamedic ASA-Key Employees 21
Navamedic ASA-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Aug 24, 2018: Navamedic: Q2 2018 results 23
May 30, 2018: Navamedic Announces Q1 2018 results 24
Feb 15, 2018: Navamedic: Q4 2017 Results 25
Nov 10, 2017: Navamedic: Q3 2017 results 26
Jul 28, 2017: Navamedic ASA: Second quarter results 2017 27
Jul 28, 2017: Navamedic: Second quarter results 2017 28
May 10, 2017: Navamedic: Q1 2017 Results 29
Feb 15, 2017: Navamedic: Q4 2016 results 30
Corporate Communications 31
Oct 01, 2018: Navamedic announce Tom Ronnlund to step down as CEO 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32
List Of Figure
List of Figures
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
List Of Table
List of Tables
Navamedic ASA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Navamedic ASA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Navamedic ASA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Navamedic ASA, Deals By Therapy Area, 2012 to YTD 2018 8
Navamedic ASA, Medical Devices Deals, 2012 to YTD 2018 9
Navamedic ASA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Navamedic Enters into Agreement with G. Pohl-Boskamp 11
Navamedic Enters into Agreement with bene-Arzneimittel 12
Orexigen Therapeutics Enters into Distribution Agreement with Navamedic 13
Navamedic Plans to Enter into Commercialization Agreement with TopRidge Pharma for Sippi 14
Navamedic Expands Distribution Agreement with TopRidge Pharma for Imdur 15
Biotec Pharmacon Enters into Distribution Agreeement with Navamedic 16
Navamedic Enters Into Distribution Agreement With Torrent Pharma 17
Navamedic Amends Distribution Agreement With Aspen Pharma 18
Navamedic Raises USD1.3 Million in Private Placement of Shares 19
Navamedic ASA, Key Competitors 20
Navamedic ASA, Key Employees 21
Navamedic ASA, Subsidiaries 22
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Navamedic ASA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.